Found: 23
Select item for more details and to access through your institution.
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 6, p. 1772, doi. 10.3390/pharmaceutics15061772
- By:
- Publication type:
- Article
Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/pharmaceutics14091782
- By:
- Publication type:
- Article
Oncostatin M is overexpressed in NASH‐related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis.
- Published in:
- Journal of Pathology, 2022, v. 257, n. 1, p. 82, doi. 10.1002/path.5871
- By:
- Publication type:
- Article
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7463, doi. 10.3390/ijms24087463
- By:
- Publication type:
- Article
Platelets, Protean Cells with All-Around Functions and Multifaceted Pharmacological Applications.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 5, p. 4565, doi. 10.3390/ijms24054565
- By:
- Publication type:
- Article
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2953, doi. 10.3390/ijms24032953
- By:
- Publication type:
- Article
ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 7363, doi. 10.3390/ijms23137363
- By:
- Publication type:
- Article
SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.910526
- By:
- Publication type:
- Article
Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.786680
- By:
- Publication type:
- Article
Inflammatory processes involved in NASH-related hepatocellular carcinoma.
- Published in:
- Bioscience Reports, 2023, v. 43, n. 1, p. 1, doi. 10.1042/BSR20221271
- By:
- Publication type:
- Article
NF<sub>-?</sub>B1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
- Published in:
- Clinical Science, 2013, v. 124, n. 4, p. 279, doi. 10.1042/CS20120289
- By:
- Publication type:
- Article
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis.
- Published in:
- Clinical Science, 2012, v. 123, n. 7, p. 459, doi. 10.1042/CS20110515
- By:
- Publication type:
- Article
Adenosine A<sub>2a</sub> receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.
- Published in:
- Clinical Science, 2012, v. 123, n. 5, p. 323, doi. 10.1042/CS20110504
- By:
- Publication type:
- Article
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunctionassociated steatohepatitis.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1290391
- By:
- Publication type:
- Article
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0172575
- By:
- Publication type:
- Article
Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 1, p. 1, doi. 10.3390/cells9010028
- By:
- Publication type:
- Article
CX3CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 9, p. 1099, doi. 10.3390/cells8091099
- By:
- Publication type:
- Article
Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis.
- Published in:
- Clinical Science, 2022, v. 136, n. 9, p. 643, doi. 10.1042/CS20211122
- By:
- Publication type:
- Article
Liver inflammation and regeneration in drug-induced liver injury: sex matters!
- Published in:
- Clinical Science, 2018, v. 132, n. 5, p. 609, doi. 10.1042/CS20171313
- By:
- Publication type:
- Article
CX<sub>3</sub>CR1 modulates the anti-inflammatory activity of hepatic dendritic cells in response to acute liver injury.
- Published in:
- Clinical Science, 2017, v. 131, n. 17, p. 2289, doi. 10.1042/CS20171025
- By:
- Publication type:
- Article
C<sub>X</sub>3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis.
- Published in:
- Clinical Science, 2015, v. 129, n. 9, p. 797, doi. 10.1042/CS20150053
- By:
- Publication type:
- Article
Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1342404
- By:
- Publication type:
- Article
Notch signaling and progenitor/ductular reaction in steatohepatitis.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0187384
- By:
- Publication type:
- Article